AstraZeneca Philippines and Medasia Medical Products Corporation have signed a partnership agreement to broaden access to machine testing that can help in the early...
AstraZeneca’s Dapagliflozin has been approved by the Food and Drug Administration for its new indication for the treatment of Chronic Kidney Disease (CKD) in...